{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:20:21Z","timestamp":1788942021114,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T00:00:00Z","timestamp":1299456000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>The improved life expectancy of patients with cystic fibrosis (CF) has led to a change in the impact of liver disease on the prognosis of this population. Liver transplantation has emerged as the procedure of choice for patients with CF and features of hepatic decompensation and for intractable variceal bleeding as a major manifestation. We retrospectively reviewed the United Network for Organ Sharing database to analyze the outcomes of 55 adults and 148 children with CF who underwent liver transplantation, and we compared them to patients who underwent transplantation for other etiologies. We additionally compared the benefits of liver transplantation among patients who underwent transplantation for cystic fibrosis-related liver disease (CFLD) and those who remained on the waiting list. The 5-year survival rates for children and adults undergoing liver transplantation were 85.8% and 72.7%, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.016). A multivariate Cox regression analysis comparing pediatric and adult CF patients to patients who underwent transplantation for other etiologies noted lower 5-year survival rates (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). However, compared to those remaining on the waiting list, pediatric transplant recipients with CF (hazard ratio = 0.33, 95% confidence interval = 0.16-0.70, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004) and adult transplant recipients with CF (hazard ratio = 0.25, 95% confidence interval = 0.11-0.57, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001) gained a significant survival benefit. In conclusion, long-term outcomes in patients with CFLD are acceptable but are inferior in comparison with the outcomes of those undergoing transplantation for other etiologies. Despite such observations, a survival benefit was noted in transplant patients versus those who remained on the waiting list. Liver Transpl, 2011. \u00a9 2011 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.22240","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T14:18:25Z","timestamp":1292336305000},"page":"243-250","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":84,"title":["Liver transplantation in patients with cystic fibrosis"],"prefix":"10.1097","volume":"17","author":[{"given":"Manuel","family":"Mendizabal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender K.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cassuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Olthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Makar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Shaked","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Abt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20250124","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis.","volume":"352","author":"Rowe","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-4-20250124","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome.","volume":"36","author":"Colombo","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R3-4-20250124","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis.","volume":"30","author":"Lindblad","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R4-4-20250124","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jcf.2007.10.004","article-title":"A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.","volume":"7","author":"Nash","year":"2008","journal-title":"J Cyst Fibros"},{"key":"R5-4-20250124","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938.","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-4-20250124","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1164\/rccm.200204-364OC","article-title":"End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms.","volume":"167","author":"Arkwright","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-4-20250124","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jmg.38.5.310","article-title":"The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis.","volume":"38","author":"Gabolde","year":"2001","journal-title":"J Med Genet"},{"key":"R8-4-20250124","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis.","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"key":"R9-4-20250124","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.2004.062786","article-title":"Patterns of GI disease in adulthood associated with mutations in the CFTR gene.","volume":"56","author":"Wilschanski","year":"2007","journal-title":"Gut"},{"key":"R10-4-20250124","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.510270126","article-title":"A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.","volume":"27","author":"Lindblad","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R11-4-20250124","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1478-3231.2007.01570.x","article-title":"The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.","volume":"27","author":"Desmond","year":"2007","journal-title":"Liver Int"},{"key":"R12-4-20250124","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0022-3468(03)00260-4","article-title":"Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single centers experience.","volume":"38","author":"Fridell","year":"2003","journal-title":"J Pediatr Surg"},{"key":"R13-4-20250124","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1432-2277.2006.00344.x","article-title":"Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry.","volume":"19","author":"Melzi","year":"2006","journal-title":"Transpl Int"},{"key":"R14-4-20250124","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-6143.2007.02028.x","article-title":"Cystic fibrosis liver disease: to transplant or not to transplant.?","volume":"8","author":"Nash","year":"2008","journal-title":"Am J Transplant"},{"key":"R15-4-20250124","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1432-2277.2004.00013.x","article-title":"Effects of liver transplantation on the nutritional status of patients with cystic fibrosis.","volume":"18","author":"Colombo","year":"2005","journal-title":"Transpl Int"},{"key":"R16-4-20250124","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1440-1746.2002.02671.x","article-title":"Transplantation for cystic fibrosis: outcome following early liver transplantation.","volume":"17","author":"Milkiewicz","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R17-4-20250124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1432-2277.1997.tb00533.x","article-title":"Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children.","volume":"10","author":"Couetil","year":"1997","journal-title":"Transpl Int"},{"key":"R18-4-20250124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R19-4-20250124","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation.","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant"},{"key":"R20-4-20250124","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00595-007-3576-7","article-title":"Liver transplantation for cystic fibrosis in adults.","volume":"38","author":"Ikegami","year":"2008","journal-title":"Surg Today"},{"issue":"suppl 27","key":"R21-4-20250124","first-page":"31","article-title":"Liver transplantation for hepatic cirrhosis in cystic fibrosis.","volume":"89","author":"Noble-Jamieson","year":"1996","journal-title":"J R Soc Med"},{"key":"R22-4-20250124","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1464-5491.2003.00924.x","article-title":"Cystic fibrosis-related diabetes.","volume":"20","author":"Mackie","year":"2003","journal-title":"Diabet Med"},{"key":"R23-4-20250124","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/lt.21070","article-title":"Combined en bloc liver pancreas transplantation for children with CF.","volume":"13","author":"Mekeel","year":"2007","journal-title":"Liver Transpl"},{"issue":"suppl 3","key":"R24-4-20250124","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/lt.20967","article-title":"Model for End-Stage Liver Disease (MELD) exception for cystic fibrosis.","volume":"12","author":"Horslen","year":"2006","journal-title":"Liver Transpl"},{"key":"R25-4-20250124","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10620-010-1267-5","article-title":"Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score.","volume":"55","author":"Samuelson","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R26-4-20250124","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcf.2004.08.001","article-title":"Clinical importance of cystic fibrosis-related diabetes.","volume":"3","author":"Brennan","year":"2004","journal-title":"J Cyst Fibros"},{"key":"R27-4-20250124","first-page":"345","article-title":"Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome.","volume":"6","author":"Rosenecker","year":"2001","journal-title":"Eur J Med Res"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22240","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22240","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201103000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T17:06:56Z","timestamp":1737738416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201103000-00004"}},"subtitle":["Analysis of united network for organ sharing data"],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.22240","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}